Evolution of anti-SARS-CoV-2 spike protein titers after two-dose of COVID-19 vaccination among people living with HIV

Evolution of anti-SARS-CoV-2 spike protein titers after two-dose of COVID-19 vaccination among people living with HIV

Background: A community COVID-19 outbreak caused by the B.1.1.7 SARS-CoV-2 variant occurred in Taiwan in May 2021. High-risk populations such as people living with HIV (PLWH) were recommended to receive two doses of COVID-19 vaccines. While SARS-CoV-2 vaccines have demonstrated promising results in...

Full description

Bibliographic Details
Main Authors: Wang-Da Liu, Man Wai Pang, Jann-Tay Wang, Hsin-Yun Sun, Yu-Shan Huang, Kuan-Yin Lin, Un-In Wu, Guei-Chi Li, Wen-Chun Liu, Yi-Ching Su, Pu-Chi He, Chia-Yi Lin, Chih-Yu Yeh, Yu-Chen Cheng, Yi Yao, Yi-Ting Chen, Pei-Ying Wu, Ling-Ya Chen, Yu-Zhen Luo, Hsi-Yen Chang, Wang-Huei Sheng, Szu-Min Hsieh, Sui-Yuan Chang, Chien-Ching Hung, Shan-Chwen Chang
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:Journal of Virus Eradication
Subjects:
Antibody
Humoral immunity
ChAdOx1 nCoV-19 (AZD1222) vaccine
mRNA-1273 vaccine
BNT162b2 vaccine
Online Access:http://www.sciencedirect.com/science/article/pii/S2055664022002461

Internet

http://www.sciencedirect.com/science/article/pii/S2055664022002461

Similar Items